Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
10/04/2026
Palladium futures fell 2% intraday, now trading at $1532.26 per ounce.
Latest
2 m ago
Analyst: Nike needs innovation and fresh blood.
3 m ago
According to the Hong Kong Stock Exchange documents: CanSino Biologics Inc. will conduct a listing hearing on the Hong Kong Stock Exchange.
3 m ago
Market news: US Brent crude futures fell about 0.5% on reports that the US may extend waivers on Russian oil.
4 m ago
Palantir's intraday gains have now narrowed to 2% after previously falling more than 6%. US President Trump stated that Palantir has been proven to have excellent combat capabilities and equipment.
5 m ago
Rongchang Biotechnology: The new indication for the treatment of locally advanced or metastatic urothelial carcinoma with HER2 expression using the combination of vedolizumab and trastuzumab has been approved for new drug market application.
See all latest